We performed proteomics based on purified CD4+ T cells from healthy individuals, untreated RA patients and RA patients treated with IL-6 receptor blocking antibodies to identify pathways that might be affected by changes in phosphorylation of VASP. The gene discussed is CD4; the disease is rheumatoid arthritis.